HER2阳性实体瘤的临床试验
总计6016个结果
-
Hoffmann-La Roche完全的
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.Shanghai De Novo Pharmatech Co., Ltd.未知
-
Merck Sharp & Dohme LLC终止
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.完全的
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
AbbVieGenentech, Inc.完全的
-
Safi ShahdaBayer; Genentech, Inc.完全的
-
Eli Lilly and Company完全的
-
University of CologneBoehringer Ingelheim完全的
-
Green Cross CorporationICON Clinical Research终止
-
Bristol-Myers Squibb撤销
-
Genzyme, a Sanofi Company完全的
-
sigma-tau i.f.r. S.p.A.Southern Europe New Drug Organization完全的
-
Mereo BioPharmaICON Clinical Research完全的
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.招聘中
-
GlaxoSmithKline完全的
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children's Hospital; Shenzhen...招聘中
-
Precirix终止抗 HER2 标准护理治疗后疾病进展的晚期/转移性 HER2 阳性乳腺癌、胃癌、胃食管结合部癌美国, 加拿大
-
Turning Point Therapeutics, Inc.撤销
-
Hanmi Pharmaceutical Company Limited主动,不招人
-
Spago Nanomedical AB招聘中
-
Dr David ZieglerEngeneic Pty Limited终止
-
Syndax Pharmaceuticals完全的
-
Masonic Cancer Center, University of Minnesota主动,不招人